Overview

Efficacy and Safety Study of Meloxicam Nanocrystal Injection for the Treatment of Moderate to Severe Pain

Status:
COMPLETED
Trial end date:
2023-07-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of meloxicam nanocrystal injection in subjects with moderate to severe pain after abdominal surgery.
Phase:
PHASE3
Details
Lead Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.